BHST - Multiplikator Forward P/S BioHarvest Sciences
Biosynthesis scaling risks and EU regulatory barriers are exerting moderate pressure on BioHarvest Sciences (BHST). On GURU.Markets, the forward price-to-sales valuation chart demonstrates a price vector where the value has stabilized at 1.00. The business fundamentals rely on the purity of soil-free cell cultivation, while stable demand for nutraceuticals minimizes the stock's dependence on macroeconomic cycles.
Rincian metrik lan analitis perusahaan BioHarvest Sciences Inc (BHST)
- rega saiki lan proyeksi nilai saham:
- statistik kapitalisasi pasar:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal BioHarvest Sciences|BHST - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioHarvest Sciences|BHST - Kewajiban utang agregat|Utang marang nilai buku BioHarvest Sciences Inc|BHST - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BioHarvest Sciences|Likuiditas cepet bioharvest.com
- data bathi bisnis lan rasio investasi:
BHST - Asil keuangan resik|Bathi mangsa ngarep BioHarvest Sciences|BHST - Rasio rega pasar marang bathi resik|Prakiraan rega marang bathi BioHarvest|BHST - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioHarvest Sciences Inc|BHST - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) BioHarvest Sciences|BHST - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan bioharvest.com|BHST - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep BioHarvest Sciences
- rincian pendapatan lan dodolan:
Ringkesan analisis perusahaan:BioHarvest Sciences Inc. (BHST)
BioHarvest Sciences (BHST) is transforming the agricultural sector through cellular bio-growth, making the expected revenue multiple a key indicator of the efficiency of scaling bioreactor capacities. This metric correlates current market value with projected revenue, allowing for an assessment of the risk of asset overvaluation should there be a deviation from resource optimization plans and sales expansion rates.
Karo sapa BioHarvest Sciences saingan
Multiplikator Forward P/S HLN (Haleon)|Kenvue Inc - Rasio rega marang prakiraan pendapatan|Verona Pharma Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Jyong Bio MENS|Ligand Pharmaceuticals (LGND) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep amneal.com (AMRX)|PRGO (Perrigo) - Multiplikator Forward P/S|ALVO: Rega forward marang dodolan|Multiplikator Forward P/S LQDA|Multiplikator Forward P/S Galapagos Corp (GLPG)|Rasio rega marang prakiraan pendapatan ANI Pharmaceuticals ANIP|Rega forward marang dodolan MNKD|AMPH: Multiplikator forward rega marang pendapatan|PCRX: Rasio rega marang prakiraan pendapatan|SPRY: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Theravance Corp (TBPH)|Rasio rega marang prakiraan pendapatan Aquestive Therapeutics|scPharma (SCPH) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan TECX (Tectonic Therapeutic, Inc.)|Rasio rega marang pendapatan sing dikarepake TNXP|China SXT Pharmaceuticals, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan EPRX|EXOZ - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Oramed Pharmaceuticals ORMP|ENTX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - Multiplikator Forward P/S|Cumberland Corp (CPIX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S QNTM|FGEN - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Telomir Pharmaceuticals, Inc. TELO|RANI: Kapitalisasi marang prakiraan pendapatan|Synergy CHC Corporation - Multiplikator Forward P/S|Rallybio Corporation (RLYB) - Multiplikator forward rega marang pendapatan|LEXX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep pulmatrix.com (PULM)|Rasio rega marang prakiraan pendapatan Pheton Holdings Limited|Aptorum (APM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S LYRA|Rasio rega marang prakiraan pendapatan IBO (Impact BioMedical, Inc.)|Multiplikator Forward P/S TNFA (TNF Pharmaceuticals, Inc.)|Rega forward marang dodolan YCBD|PRFX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Altamira Therapeutics CYTO|LIPO (Lipella) - Multiplikator forward rega marang pendapatan|OPTN: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals|procapsgroup.com - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S PTPI|QLI (Qilian International Holding Group) - Rega forward marang dodolan|Multiplikator Forward P/S SLRN (ACELYRIN, Inc.)|Multiplikator Forward P/S TFF Pharmaceuticals, Inc TFFP
